25 XP   0   0   10

Centogene B V
Buy, Hold or Sell?

Let's analyse Centogene together

PenkeI guess you are interested in Centogene B V. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Centogene B V. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Centogene B V

I send you an email if I find something interesting about Centogene B V.

Quick analysis of Centogene (30 sec.)










What can you expect buying and holding a share of Centogene? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.59
Expected worth in 1 year
$-1.98
How sure are you?
34.8%

+ What do you gain per year?

Total Gains per Share
$-1.40
Return On Investment
-321.9%

For what price can you sell your share?

Current Price per Share
$0.43
Expected price per share
$0 - $0.75
How sure are you?
50%

1. Valuation of Centogene (5 min.)




Live pricePrice per Share (EOD)

$0.43

Intrinsic Value Per Share

$-3.15 - $-3.66

Total Value Per Share

$-3.74 - $-4.25

2. Growth of Centogene (5 min.)




Is Centogene growing?

Current yearPrevious yearGrowGrow %
How rich?-$16.3m$31.8m-$22.6m-246.2%

How much money is Centogene making?

Current yearPrevious yearGrowGrow %
Making money-$9.4m-$14m$4.5m48.1%
Net Profit Margin-54.8%-67.3%--

How much money comes from the company's main activities?

3. Financial Health of Centogene (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#110 / 145

Most Revenue
#73 / 145

Most Profit
#129 / 145

Most Efficient
#103 / 145

What can you expect buying and holding a share of Centogene? (5 min.)

Welcome investor! Centogene's management wants to use your money to grow the business. In return you get a share of Centogene.

What can you expect buying and holding a share of Centogene?

First you should know what it really means to hold a share of Centogene. And how you can make/lose money.

Speculation

The Price per Share of Centogene is $0.434. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Centogene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Centogene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.59. Based on the TTM, the Book Value Change Per Share is $-0.35 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Centogene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.47-108.5%-0.47-108.5%-0.50-115.8%-0.33-75.5%-0.30-69.3%
Usd Book Value Change Per Share-0.87-200.8%-0.35-80.5%-0.35-79.9%-0.06-14.0%-0.03-5.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.87-200.8%-0.35-80.5%-0.35-79.9%-0.06-14.0%-0.03-5.9%
Usd Price Per Share1.50-1.05-5.70-6.14-5.34-
Price to Earnings Ratio-0.80--0.56--2.90--3.51--3.05-
Price-to-Total Gains Ratio-1.72--1.48--3.22--1.66--1.66-
Price to Book Ratio-2.56-0.57-4.71-3.33-2.90-
Price-to-Total Gains Ratio-1.72--1.48--3.22--1.66--1.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.434
Number of shares2304
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.35-0.06
Usd Total Gains Per Share-0.35-0.06
Gains per Quarter (2304 shares)-804.69-140.09
Gains per Year (2304 shares)-3,218.75-560.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3219-32290-560-570
20-6437-64480-1121-1130
30-9656-96670-1681-1690
40-12875-128860-2241-2250
50-16094-161050-2802-2810
60-19312-193240-3362-3370
70-22531-225430-3923-3930
80-25750-257620-4483-4490
90-28969-289810-5043-5050
100-32187-322000-5604-5610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.022.00.04.3%1.022.00.04.3%
Book Value Change Per Share0.02.02.00.0%3.06.03.025.0%7.09.04.035.0%8.09.06.034.8%8.09.06.034.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share0.02.02.00.0%3.06.03.025.0%7.09.04.035.0%8.09.06.034.8%8.09.06.034.8%

Fundamentals of Centogene

About Centogene B V

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Fundamental data was last updated by Penke on 2024-05-02 14:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Centogene B V.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Centogene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -99.3% means that $-0.99 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Centogene B V:

  • The MRQ is -99.3%. The company is making a huge loss. -2
  • The TTM is -54.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-99.3%TTM-54.8%-44.5%
TTM-54.8%YOY-67.3%+12.5%
TTM-54.8%5Y-43.4%-11.4%
5Y-43.4%10Y-41.6%-1.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-99.3%-7.3%-92.0%
TTM-54.8%-6.7%-48.1%
YOY-67.3%-1.9%-65.4%
5Y-43.4%-1.5%-41.9%
10Y-41.6%-3.4%-38.2%
1.1.2. Return on Assets

Shows how efficient Centogene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • -17.0% Return on Assets means that Centogene generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Centogene B V:

  • The MRQ is -17.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.0%TTM-10.6%-6.4%
TTM-10.6%YOY-13.8%+3.2%
TTM-10.6%5Y-7.3%-3.3%
5Y-7.3%10Y-7.0%-0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.0%-1.3%-15.7%
TTM-10.6%-1.3%-9.3%
YOY-13.8%-0.9%-12.9%
5Y-7.3%-0.5%-6.8%
10Y-7.0%-0.9%-6.1%
1.1.3. Return on Equity

Shows how efficient Centogene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Centogene generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Centogene B V:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-44.5%+44.5%
TTM-44.5%YOY-44.9%+0.4%
TTM-44.5%5Y-26.2%-18.2%
5Y-26.2%10Y-24.8%-1.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.5%+0.5%
TTM-44.5%0.2%-44.7%
YOY-44.9%-0.3%-44.6%
5Y-26.2%-1.4%-24.8%
10Y-24.8%-2.3%-22.5%

1.2. Operating Efficiency of Centogene B V.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Centogene is operating .

  • Measures how much profit Centogene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • An Operating Margin of -86.3% means the company generated $-0.86  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Centogene B V:

  • The MRQ is -86.3%. The company is operating very inefficient. -2
  • The TTM is -49.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-86.3%TTM-49.4%-36.9%
TTM-49.4%YOY-76.0%+26.5%
TTM-49.4%5Y-42.3%-7.1%
5Y-42.3%10Y-40.3%-2.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-86.3%-7.4%-78.9%
TTM-49.4%0.5%-49.9%
YOY-76.0%4.0%-80.0%
5Y-42.3%3.7%-46.0%
10Y-40.3%-1.3%-39.0%
1.2.2. Operating Ratio

Measures how efficient Centogene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are $1.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Centogene B V:

  • The MRQ is 1.881. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.263. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.881TTM1.263+0.618
TTM1.263YOY1.760-0.497
TTM1.2635Y1.377-0.114
5Y1.37710Y1.364+0.013
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8811.280+0.601
TTM1.2631.304-0.041
YOY1.7601.236+0.524
5Y1.3771.242+0.135
10Y1.3641.205+0.159

1.3. Liquidity of Centogene B V.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Centogene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.45 means the company has $1.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Centogene B V:

  • The MRQ is 1.446. The company is just able to pay all its short-term debts.
  • The TTM is 0.968. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.446TTM0.968+0.478
TTM0.968YOY1.908-0.940
TTM0.9685Y1.432-0.464
5Y1.43210Y1.270+0.162
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4462.122-0.676
TTM0.9682.298-1.330
YOY1.9082.599-0.691
5Y1.4323.012-1.580
10Y1.2703.081-1.811
1.3.2. Quick Ratio

Measures if Centogene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.19 means the company can pay off $1.19 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Centogene B V:

  • The MRQ is 1.192. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.830. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.192TTM0.830+0.362
TTM0.830YOY1.537-0.707
TTM0.8305Y1.165-0.335
5Y1.16510Y1.031+0.133
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1921.230-0.038
TTM0.8301.345-0.515
YOY1.5371.661-0.124
5Y1.1651.957-0.792
10Y1.0312.295-1.264

1.4. Solvency of Centogene B V.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Centogene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Centogene to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 1.21 means that Centogene assets are financed with 121.2% credit (debt) and the remaining percentage (100% - 121.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Centogene B V:

  • The MRQ is 1.212. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.916. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.212TTM0.916+0.296
TTM0.916YOY0.693+0.223
TTM0.9165Y0.700+0.216
5Y0.70010Y0.701-0.001
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2120.429+0.783
TTM0.9160.407+0.509
YOY0.6930.394+0.299
5Y0.7000.448+0.252
10Y0.7010.446+0.255
1.4.2. Debt to Equity Ratio

Measures if Centogene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Centogene to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Centogene B V:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.518-4.518
TTM4.518YOY2.370+2.148
TTM4.5185Y2.720+1.798
5Y2.72010Y2.675+0.045
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.606-0.606
TTM4.5180.571+3.947
YOY2.3700.603+1.767
5Y2.7200.651+2.069
10Y2.6750.734+1.941

2. Market Valuation of Centogene B V

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Centogene generates.

  • Above 15 is considered overpriced but always compare Centogene to the Diagnostics & Research industry mean.
  • A PE ratio of -0.80 means the investor is paying $-0.80 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Centogene B V:

  • The EOD is -0.230. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.796. Based on the earnings, the company is expensive. -2
  • The TTM is -0.558. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.230MRQ-0.796+0.566
MRQ-0.796TTM-0.558-0.238
TTM-0.558YOY-2.899+2.341
TTM-0.5585Y-3.506+2.948
5Y-3.50610Y-3.049-0.457
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.230-0.254+0.024
MRQ-0.796-0.395-0.401
TTM-0.558-0.199-0.359
YOY-2.899-0.008-2.891
5Y-3.5063.483-6.989
10Y-3.0494.432-7.481
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Centogene B V:

  • The EOD is -0.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.342. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.866. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.388MRQ-1.342+0.954
MRQ-1.342TTM-0.866-0.476
TTM-0.866YOY-4.813+3.947
TTM-0.8665Y-3.461+2.596
5Y-3.46110Y-3.010-0.451
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.388-0.315-0.073
MRQ-1.342-0.441-0.901
TTM-0.866-1.388+0.522
YOY-4.813-2.175-2.638
5Y-3.461-1.665-1.796
10Y-3.010-1.971-1.039
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Centogene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -2.56 means the investor is paying $-2.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Centogene B V:

  • The EOD is -0.740. Based on the equity, the company is expensive. -2
  • The MRQ is -2.559. Based on the equity, the company is expensive. -2
  • The TTM is 0.565. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.740MRQ-2.559+1.818
MRQ-2.559TTM0.565-3.124
TTM0.565YOY4.710-4.145
TTM0.5655Y3.330-2.765
5Y3.33010Y2.896+0.434
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.7401.946-2.686
MRQ-2.5592.228-4.787
TTM0.5652.168-1.603
YOY4.7103.002+1.708
5Y3.3303.517-0.187
10Y2.8964.125-1.229
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Centogene B V.

3.1. Institutions holding Centogene B V

Institutions are holding 65.215% of the shares of Centogene B V.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Junked Platinum Investment Management Ltd8.52820.11582376442-708-0.0298
2023-12-31Wells Fargo & Co0.73710.0001205389-1000-0.4845
2023-12-31BlackRock Inc0.077402157800
2023-12-31Stifel Financial Corp0.077021450500030.3951
2023-12-31Millennium Management LLC0.0651018136-1595-8.0837
2023-12-31Barclays PLC0.055101534800
2023-12-31Apollon Wealth Management, LLC0.04520.000512595125950
2023-12-31Geode Capital Management, LLC0.0401115600
2023-12-31Morgan Stanley - Brokerage Accounts0.028808031-10200-55.9487
2023-12-31UBS Group AG0.0040110911090
2023-12-31Meeder Asset Management Inc0.0005013800
2023-09-30Royal Bank of Canada0.0002050500
2023-12-31JPMorgan Chase & Co001300
2023-12-31Qube Research & Technologies00200
2023-12-31Acadian Asset Management LLC000-24703-100
2023-09-30Two Sigma Investments LLC000-11918-100
Total 9.65860.11642691437-31370-1.2%

3.2. Funds holding Centogene B V

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29ACATIS Datini Valueflex Fonds A1.27220.02935449800
2024-02-29Fidelity Nasdaq Composite Index0.040.00011115600
2024-02-29Platinum World Portfolios-Intl D USD Acc0.0140.0066390200
2023-12-31NT Quality Small Cap Core0.01120.0016312200
2023-12-31NT Quality SCC US Fund - L0.01120.0015312200
2024-03-31Meeder Conservative Allocation Retail0.00050.000113800
Total 1.34910.038937593800.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Centogene B V compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.872-0.349-60%-0.347-60%-0.061-93%-0.025-97%
Book Value Per Share---0.5860.330-278%1.143-151%1.295-145%1.208-149%
Current Ratio--1.4460.968+49%1.908-24%1.432+1%1.270+14%
Debt To Asset Ratio--1.2120.916+32%0.693+75%0.700+73%0.701+73%
Debt To Equity Ratio---4.518-100%2.370-100%2.720-100%2.675-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.471-0.4710%-0.503+7%-0.327-30%-0.301-36%
Free Cash Flow Per Share---0.279-0.233-17%-0.298+7%-0.132-53%-0.142-49%
Free Cash Flow To Equity Per Share---0.379-0.070-82%-0.023-94%0.128-397%0.099-483%
Gross Profit Margin--1.2741.220+4%1.253+2%1.317-3%1.409-10%
Intrinsic Value_10Y_max---3.663--------
Intrinsic Value_10Y_min---3.153--------
Intrinsic Value_1Y_max---0.318--------
Intrinsic Value_1Y_min---0.312--------
Intrinsic Value_3Y_max---0.992--------
Intrinsic Value_3Y_min---0.947--------
Intrinsic Value_5Y_max---1.712--------
Intrinsic Value_5Y_min---1.586--------
Market Cap12093757.200-246%41798700.00029286955.800+43%158967422.550-74%171072326.070-76%148758544.409-72%
Net Profit Margin---0.993-0.548-45%-0.673-32%-0.434-56%-0.416-58%
Operating Margin---0.863-0.494-43%-0.760-12%-0.423-51%-0.403-53%
Operating Ratio--1.8811.263+49%1.760+7%1.377+37%1.364+38%
Pb Ratio-0.740+71%-2.5590.565-553%4.710-154%3.330-177%2.896-188%
Pe Ratio-0.230+71%-0.796-0.558-30%-2.899+264%-3.506+340%-3.049+283%
Price Per Share0.434-246%1.5001.051+43%5.705-74%6.139-76%5.338-72%
Price To Free Cash Flow Ratio-0.388+71%-1.342-0.866-36%-4.813+259%-3.461+158%-3.010+124%
Price To Total Gains Ratio-0.498+71%-1.721-1.483-14%-3.220+87%-1.659-4%-1.659-4%
Quick Ratio--1.1920.830+44%1.537-22%1.165+2%1.031+16%
Return On Assets---0.170-0.106-38%-0.138-19%-0.073-57%-0.070-59%
Return On Equity----0.4450%-0.4490%-0.2620%-0.2480%
Total Gains Per Share---0.872-0.349-60%-0.347-60%-0.061-93%-0.025-97%
Usd Book Value---16336250.4009200811.900-278%31857137.100-151%36078939.719-145%33662266.642-149%
Usd Book Value Change Per Share---0.872-0.349-60%-0.347-60%-0.061-93%-0.025-97%
Usd Book Value Per Share---0.5860.330-278%1.143-151%1.295-145%1.208-149%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.471-0.4710%-0.503+7%-0.327-30%-0.301-36%
Usd Free Cash Flow---7787139.200-4861327.700-38%-8308982.700+7%-3490743.980-55%-3794928.522-51%
Usd Free Cash Flow Per Share---0.279-0.233-17%-0.298+7%-0.132-53%-0.142-49%
Usd Free Cash Flow To Equity Per Share---0.379-0.070-82%-0.023-94%0.128-397%0.099-483%
Usd Market Cap12093757.200-246%41798700.00029286955.800+43%158967422.550-74%171072326.070-76%148758544.409-72%
Usd Price Per Share0.434-246%1.5001.051+43%5.705-74%6.139-76%5.338-72%
Usd Profit---13123089.600-9476221.850-28%-14035309.600+7%-7272083.690-45%-6678920.217-49%
Usd Revenue--13213238.40010301646.800+28%25385741.100-48%24623447.140-46%22613910.470-42%
Usd Total Gains Per Share---0.872-0.349-60%-0.347-60%-0.061-93%-0.025-97%
 EOD+2 -6MRQTTM+11 -20YOY+11 -225Y+5 -2810Y+5 -28

4.2. Fundamental Score

Let's check the fundamental score of Centogene B V based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.230
Price to Book Ratio (EOD)Between0-1-0.740
Net Profit Margin (MRQ)Greater than0-0.993
Operating Margin (MRQ)Greater than0-0.863
Quick Ratio (MRQ)Greater than11.192
Current Ratio (MRQ)Greater than11.446
Debt to Asset Ratio (MRQ)Less than11.212
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.170
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Centogene B V based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.795
Ma 20Greater thanMa 500.515
Ma 50Greater thanMa 1000.637
Ma 100Greater thanMa 2000.888
OpenGreater thanClose0.430
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets71,892
Total Liabilities87,114
Total Stockholder Equity-15,222
 As reported
Total Liabilities 87,114
Total Stockholder Equity+ -15,222
Total Assets = 71,892

Assets

Total Assets71,892
Total Current Assets38,911
Long-term Assets32,981
Total Current Assets
Cash And Cash Equivalents 14,153
Net Receivables 17,919
Inventory 2,129
Other Current Assets 4,710
Total Current Assets  (as reported)38,911
Total Current Assets  (calculated)38,911
+/-0
Long-term Assets
Property Plant Equipment 21,614
Intangible Assets 8,180
Other Assets 3,187
Long-term Assets  (as reported)32,981
Long-term Assets  (calculated)32,981
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities26,902
Long-term Liabilities60,212
Total Stockholder Equity-15,222
Total Current Liabilities
Short-term Debt 6,812
Short Long Term Debt 4,501
Accounts payable 6,951
Other Current Liabilities 11,966
Total Current Liabilities  (as reported)26,902
Total Current Liabilities  (calculated)30,230
+/- 3,328
Long-term Liabilities
Long term Debt 39,634
Capital Lease Obligations 15,770
Other Liabilities 7,119
Long-term Liabilities Other 101
Long-term Liabilities  (as reported)60,212
Long-term Liabilities  (calculated)62,624
+/- 2,412
Total Stockholder Equity
Common Stock3,412
Retained Earnings -164,818
Other Stockholders Equity 146,184
Total Stockholder Equity (as reported)-15,222
Total Stockholder Equity (calculated)-15,222
+/-0
Other
Capital Stock3,412
Cash and Short Term Investments 14,153
Common Stock Shares Outstanding 27,791
Current Deferred Revenue1,173
Liabilities and Stockholders Equity 71,892
Net Debt 45,752
Net Invested Capital 28,913
Net Tangible Assets -23,402
Net Working Capital 12,009
Property Plant and Equipment Gross 21,614
Short Long Term Debt Total 59,905



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
55,486
0
0
69,700
76,674
188,238
75,309
73,787
117,510
117,510
102,915
121,739
150,130
150,130
120,786
96,190
90,694
108,102
90,163
0
0
92,812
71,892
71,89292,8120090,163108,10290,69496,190120,786150,130150,130121,739102,915117,510117,51073,78775,309188,23876,67469,7000055,486
   > Total Current Assets 
13,440
3,157
0
20,467
28,764
9,222
26,292
29,858
68,109
68,109
48,926
65,881
97,046
97,046
68,615
50,409
51,477
71,301
55,339
0
0
59,832
38,911
38,91159,8320055,33971,30151,47750,40968,61597,04697,04665,88148,92668,10968,10929,85826,2929,22228,76420,46703,15713,440
       Cash And Cash Equivalents 
3,157
-3,157
0
1,973
9,222
-9,222
3,564
6,061
36,595
36,595
17,400
28,748
43,156
43,156
29,780
20,732
13,380
38,228
33,515
0
0
35,951
14,153
14,15335,9510033,51538,22813,38020,73229,78043,15643,15628,74817,40036,59536,5956,0613,564-9,2229,2221,9730-3,1573,157
       Short-term Investments 
0
6,314
0
0
0
18,444
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000018,4440006,3140
       Net Receivables 
6,992
0
0
13,145
13,071
42,447
15,653
16,347
19,359
19,359
14,983
25,787
29,199
29,199
18,490
13,907
24,337
21,125
15,716
0
16,548
16,548
17,919
17,91916,54816,548015,71621,12524,33713,90718,49029,19929,19925,78714,98319,35919,35916,34715,65342,44713,07113,145006,992
       Inventory 
779
0
0
1,748
1,346
4,264
1,706
1,586
1,809
1,809
8,061
7,291
11,405
11,405
9,281
4,922
3,869
2,067
2,154
0
1,819
1,819
2,129
2,1291,8191,81902,1542,0673,8694,9229,28111,40511,4057,2918,0611,8091,8091,5861,7064,2641,3461,74800779
       Other Current Assets 
2,512
0
0
3,601
5,125
8,948
5,369
5,864
5,846
5,846
8,482
4,055
8,286
8,286
6,064
5,848
5,453
5,443
3,954
5,514
0
5,514
4,710
4,7105,51405,5143,9545,4435,4535,8486,0648,2868,2864,0558,4825,8465,8465,8645,3698,9485,1253,601002,512
   > Long-term Assets 
41,317
0
0
46,893
47,910
0
49,017
43,929
49,401
49,401
53,989
55,858
53,084
53,084
52,171
45,781
39,217
36,801
34,824
0
0
32,980
32,981
32,98132,9800034,82436,80139,21745,78152,17153,08453,08455,85853,98949,40149,40143,92949,017047,91046,8930041,317
       Property Plant Equipment 
33,837
0
0
38,019
39,115
37,838
37,838
28,463
33,308
33,308
35,534
37,500
38,710
38,710
36,969
31,401
27,051
25,646
24,276
0
22,159
22,159
21,614
21,61422,15922,159024,27625,64627,05131,40136,96938,71038,71037,50035,53433,30833,30828,46337,83837,83839,11538,0190033,837
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
0
0
0
0
000018000000000000000000
       Intangible Assets 
7,480
0
0
8,874
8,795
27,942
11,179
12,466
14,145
14,145
0
42,976
12,407
12,407
0
0
9,194
0
7,558
0
0
7,400
8,180
8,1807,400007,55809,1940012,40712,40742,976014,14514,14512,46611,17927,9428,7958,874007,480
       Other Assets 
729
0
0
2,340
0
0
0
3,000
1,948
2,098
2,003
1,953
1,967
3,023
3,023
2,973
2,972
2,972
0
0
0
3,421
3,187
3,1873,4210002,9722,9722,9733,0233,0231,9671,9532,0032,0981,9483,0000002,34000729
> Total Liabilities 
39,132
0
0
49,492
50,150
149,595
59,849
62,599
58,588
58,588
61,433
62,384
84,353
84,353
63,712
58,814
63,191
75,296
69,111
0
0
85,401
87,114
87,11485,4010069,11175,29663,19158,81463,71284,35384,35362,38461,43358,58858,58862,59959,849149,59550,15049,4920039,132
   > Total Current Liabilities 
23,808
0
0
20,977
24,283
88,756
35,509
36,550
29,000
29,000
32,222
34,316
57,118
57,118
38,417
34,678
39,496
28,698
23,161
0
0
24,665
26,902
26,90224,6650023,16128,69839,49634,67838,41757,11857,11834,31632,22229,00029,00036,55035,50988,75624,28320,9770023,808
       Short-term Debt 
0
0
0
0
5,052
0
6,915
7,164
7,323
7,323
7,778
7,914
6,020
6,020
7,182
7,063
7,224
6,527
4,443
0
0
4,635
6,812
6,8124,635004,4436,5277,2247,0637,1826,0206,0207,9147,7787,3237,3237,1646,91505,0520000
       Short Long Term Debt 
0
0
0
0
5,355
4,452
5,524
4,262
3,688
3,852
4,367
4,619
2,492
3,994
3,883
3,842
3,815
3,574
1,730
0
0
0
4,501
4,5010001,7303,5743,8153,8423,8833,9942,4924,6194,3673,8523,6884,2625,5244,4525,3550000
       Accounts payable 
5,289
0
0
6,815
5,429
18,807
7,524
8,709
8,554
8,554
8,828
12,052
31,736
31,736
14,014
8,810
11,252
5,897
4,757
6,317
6,317
6,317
6,951
6,9516,3176,3176,3174,7575,89711,2528,81014,01431,73631,73612,0528,8288,5548,5548,7097,52418,8075,4296,815005,289
       Other Current Liabilities 
18,519
0
0
14,162
13,802
52,665
21,070
20,677
13,123
13,123
14,232
13,000
18,020
18,020
15,869
17,430
19,652
14,757
12,610
0
0
13,713
11,966
11,96613,7130012,61014,75719,65217,43015,86918,02018,02013,00014,23213,12313,12320,67721,07052,66513,80214,1620018,519
   > Long-term Liabilities 
2,000
0
0
13,401
25,867
0
24,340
26,049
29,588
29,588
29,211
28,068
27,235
27,235
25,295
24,136
23,695
46,598
45,950
0
0
60,736
60,212
60,21260,7360045,95046,59823,69524,13625,29527,23527,23528,06829,21129,58829,58826,04924,340025,86713,401002,000
       Long term Debt Total 
0
0
0
19,615
38,215
0
13,450
16,136
19,647
19,594
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000019,59419,64716,13613,450038,21519,615000
       Other Liabilities 
0
0
0
0
14,789
10,890
10,890
9,913
9,941
9,894
9,696
9,515
9,157
8,867
8,886
8,476
8,107
10,168
0
0
7,560
7,119
7,119
7,1197,1197,5600010,1688,1078,4768,8868,8679,1579,5159,6969,8949,9419,91310,89010,89014,7890000
> Total Stockholder Equity
16,736
16,354
0
20,947
27,281
26,524
16,343
12,101
59,860
59,860
41,535
59,381
65,682
65,682
56,933
37,183
27,310
32,586
21,106
0
0
7,411
-15,222
-15,2227,4110021,10632,58627,31037,18356,93365,68265,68259,38141,53559,86059,86012,10116,34326,52427,28120,947016,35416,736
   Common Stock
262
0
0
296
322
322
322
322
2,383
2,383
2,383
2,653
2,654
2,654
2,693
2,701
2,708
3,250
3,250
3,307
0
3,307
3,412
3,4123,30703,3073,2503,2502,7082,7012,6932,6542,6542,6532,3832,3832,38332232232232229600262
   Retained Earnings -164,818-141,265-141,2650-126,171-114,120-109,295-97,523-75,913-62,888-62,888-66,073-60,340-40,622-40,622-35,638-31,390-31,384-19,964-16,47500-8,985
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
25,459
0
0
37,126
61,717
47,405
47,405
47,410
7,802
8,935
99,439
107,473
58,922
58,922
22,576
24,522
27,503
25,903
0
0
0
121,018
146,184
146,184121,01800025,90327,50324,52222,57658,92258,922107,47399,4398,9357,80247,41047,40547,40561,71737,1260025,459



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue47,473
Cost of Revenue-27,712
Gross Profit19,76119,761
 
Operating Income (+$)
Gross Profit19,761
Operating Expense-56,278
Operating Income-36,517-36,517
 
Operating Expense (+$)
Research Development17,488
Selling General Administrative29,206
Selling And Marketing Expenses9,924
Operating Expense56,27856,618
 
Net Interest Income (+$)
Interest Income3
Interest Expense-3,571
Other Finance Cost-134
Net Interest Income-3,434
 
Pretax Income (+$)
Operating Income-36,517
Net Interest Income-3,434
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-38,596-34,438
EBIT - interestExpense = -40,088
-38,596
-35,132
Interest Expense3,571
Earnings Before Interest and Taxes (EBIT)-36,517-35,025
Earnings Before Interest and Taxes (EBITDA)-26,002
 
After tax Income (+$)
Income Before Tax-38,596
Tax Provision-107
Net Income From Continuing Ops-38,703-38,703
Net Income-38,703
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations6,862
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses83,990
Total Other Income/Expenses Net-2,0793,434
 

Technical Analysis of Centogene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Centogene. The general trend of Centogene is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Centogene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Centogene B V.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.431 < 0.55 < 0.75.

The bearish price targets are: .

Tweet this
Centogene B V Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Centogene B V. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Centogene B V Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Centogene B V. The current macd is -0.06650109.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Centogene price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Centogene. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Centogene price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Centogene B V Daily Moving Average Convergence/Divergence (MACD) ChartCentogene B V Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Centogene B V. The current adx is 40.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Centogene shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Centogene B V Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Centogene B V. The current sar is 0.53838474.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Centogene B V Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Centogene B V. The current rsi is 31.80. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Centogene B V Daily Relative Strength Index (RSI) ChartCentogene B V Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Centogene B V. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Centogene price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Centogene B V Daily Stochastic Oscillator ChartCentogene B V Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Centogene B V. The current cci is -79.80851083.

Centogene B V Daily Commodity Channel Index (CCI) ChartCentogene B V Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Centogene B V. The current cmo is -36.25268999.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Centogene B V Daily Chande Momentum Oscillator (CMO) ChartCentogene B V Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Centogene B V. The current willr is -84.3373494.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Centogene B V Daily Williams %R ChartCentogene B V Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Centogene B V.

Centogene B V Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Centogene B V. The current atr is 0.0583932.

Centogene B V Daily Average True Range (ATR) ChartCentogene B V Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Centogene B V. The current obv is 89,655,565.

Centogene B V Daily On-Balance Volume (OBV) ChartCentogene B V Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Centogene B V. The current mfi is 52.12.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Centogene B V Daily Money Flow Index (MFI) ChartCentogene B V Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Centogene B V.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Centogene B V Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Centogene B V based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.795
Ma 20Greater thanMa 500.515
Ma 50Greater thanMa 1000.637
Ma 100Greater thanMa 2000.888
OpenGreater thanClose0.430
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Centogene with someone you think should read this too:
  • Are you bullish or bearish on Centogene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Centogene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Centogene B V

I send you an email if I find something interesting about Centogene B V.


Comments

How you think about this?

Leave a comment

Stay informed about Centogene B V.

Receive notifications about Centogene B V in your mailbox!